Address
Giefinggasse 4
Vienna
1210, Austria
Contact
Ivan Barisic+4366488390643
ivan.barisic@ait.ac.at
Website
Novel technologies for high multiplex detection
In the last 15 years, we have developed a wide panel of in vitro and in silico technologies for the characterisation of pathogens (species, antibiotic resistance, and virulence factor identification).
In our unit, assays detecting up to 1000 different genetic targets with a single test were designed including their experimental evaluation and pre-clinical validation. Based on this comprehensive know-how, we can offer our partners and customers a wide range of services such as technology consulting, assay development, and support for the clinical validation of the final assays.
- Microbial diagnostics
- Infection prevention
- Antimicrobial stewardship
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
- Institute
- Company
- Academia
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Sell
- Joint Venture
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
N.A.
Public research organisation
Bioinformatics
• Automated sequence database management
• High-throughput design tools for DNA-based multiplex assays
• Design of complex protein/DNA nanostructures
Experimental evaluation of primer artefacts
• Nano-fluidic qPCR for identification of unintended background DNA and primer interactions
• NGS-based primer dimer sequencing
• In silico analysis of oligonucleotide interactions
Assay performance analysis
Assay development
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!